UBE2D3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.783800E-01
Normal-vs-Stage2
8.869200E-01
Normal-vs-Stage3
5.097000E-01
Normal-vs-Stage4
4.156200E-01
Stage1-vs-Stage2
9.577400E-01
Stage1-vs-Stage3
4.360600E-01
Stage1-vs-Stage4
3.457200E-01
Stage2-vs-Stage3
4.479000E-01
Stage2-vs-Stage4
6.321600E-02
Stage3-vs-Stage4
2.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.221200E-01
Normal-vs-AfricanAmerican
8.125400E-01
Normal-vs-Asian
4.676600E-01
Caucasian-vs-AfricanAmerican
5.437000E-01
Caucasian-vs-Asian
2.773600E-01
AfricanAmerican-vs-Asian
2.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.642400E-01
Normal-vs-Female
9.637800E-01
Male-vs-Female
3.863400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.506800E-01
Normal-vs-Age(41-60Yrs)
5.391400E-01
Normal-vs-Age(61-80Yrs)
6.691400E-01
Normal-vs-Age(81-100Yrs)
6.368200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.967400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.301600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.415000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.841600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.150300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.324200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.523800E-01
Normal-vs-Daily Drinker
6.119800E-01
Normal-vs-Weekly Drinker
3.865400E-01
Normal-vs-Occasional Drinker
5.466600E-01
Normal-vs-Social Drinker
9.767800E-01
Non Drinker-vs-Daily Drinker
8.555800E-01
Non Drinker-vs-Weekly Drinker
6.918400E-01
Non Drinker-vs-Occasional Drinker
1.944050E-02
Non Drinker-vs-Social Drinker
2.548600E-01
Daily Drinker-vs-Weekly Drinker
5.907000E-01
Daily Drinker-vs-Occasional Drinker
3.968400E-02
Daily Drinker-vs-Social Drinker
3.505600E-01
Weekly Drinker-vs-Occasional Drinker
1.943750E-02
Weekly Drinker-vs-Social Drinker
1.808770E-01
Occasional Drinker-vs-Social Drinker
3.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.551160E-01
Normal-vs-Grade 2
1.203950E-02
Normal-vs-Grade 3
1.933560E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.568200E-01
Grade 1-vs-Grade 3
1.706780E-01
Grade 1-vs-Grade 4
1.551160E-01
Grade 2-vs-Grade 3
4.520400E-01
Grade 2-vs-Grade 4
1.203950E-02
Grade 3-vs-Grade 4
1.933560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.131400E-01
Normal-vs-NonDiabetic
9.129600E-01
Diabetic-vs-NonDiabetic
2.078400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.025400E-01
Normal-vs-NoPancreatitis
8.615400E-01
Pancreatitis-vs-NoPancreatitis
9.992000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.565000E-01
Normal-vs-N1
9.046600E-01
N0-vs-N1
5.460800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.445200E-01
Normal-vs-TP53-NonMutant
6.952600E-01
TP53-Mutant-vs-TP53-NonMutant
4.832400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
